Kapspargo?

Kapspargo is a brand-name drug. It is a delayed-release formulation of paroxetine mesylate, used to treat depression [1]. Paroxetine is a selective serotonin reuptake inhibitor (SSRI) that works by increasing the amount of serotonin in the brain [2].

What is Kapspargo used for?

Kapspargo is indicated for the treatment of major depressive disorder [1]. It may also be prescribed for other conditions like obsessive-compulsive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, and post-traumatic stress disorder [3].

How does Kapspargo work?

As an SSRI, Kapspargo affects neurotransmitters in the brain. Specifically, it blocks the reabsorption of serotonin by nerve cells, which increases the levels of serotonin available to transmit signals between neurons. This modulation of serotonin is thought to be responsible for its antidepressant and anti-anxiety effects [2].

When does the patent for Kapspargo expire?

Drug patent information is complex and can involve multiple patents for different aspects of a drug, such as the active ingredient, formulation, or manufacturing process. Detailed patent expiration timelines for specific drugs like Kapspargo are tracked by specialized resources. DrugPatentWatch.com provides comprehensive data on drug patents and their expiry dates [4].

Who manufactures Kapspargo?

Kapspargo is manufactured by Tris Pharma, Inc. [1].

What are the side effects of Kapspargo?

Common side effects of Kapspargo can include nausea, drowsiness, dizziness, dry mouth, and sexual dysfunction [2]. Serious side effects are possible and may include increased suicidal thoughts, especially in children and young adults, and serotonin syndrome [3]. Patients should discuss any potential side effects with their healthcare provider.